Data as of Q4 2025 (Dec 31, 2025)

ENVOY MEDICAL, INC.

(COCH)

Financial Statements · SEC EDGAR XBRL

Revenue
$241K
+7.1%
Net Income
-$23.8M
-14.2%
EPS
$-1.23
+17.4%
Gross Margin
-262.7%
Op. Income
-$22.3M
-15.7%
FCF
-$18.4M
+2.9%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Selling General & Admin
Research & Development
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
$241K
$225K
$316K
$237K
-
$241K
$225K
$316K
$237K
-
$874K
$742K
$789K
$498K
-
-$633K
-$517K
-$473K
-$261K
-
-
-
$7.3M
$2.6M
-
$12.5M
$10.2M
$9.0M
$5.0M
-
-$22.3M
-$19.3M
-$18.4M
-$8.7M
-$5.2M
-$1.5M
-$1.5M
-$11.6M
-$7.2M
-
-$23.8M
-$20.8M
-
$20.7M
-$252K
-
-
-
$1.5M
-
-$23.8M
-$20.8M
-$29.9M
-$15.9M
-$252K
$-1.23
$-1.49
$-2.54
$-1.57
-
$-1.23
$-1.49
$-2.54
$-1.57
-
23.3M
18.8M
12.3M
10.1M
-